Gregory W Mattingly (Greg Mattingly)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Combination Therapy

Major Depressive Disorder

End Stage Renal Disease

Top Venues

Translational psychiatry

Postgraduate medicine

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Gregory W Mattingly, Julie A Carbray, Perry Roy, Frank A López
Are all ADHD medications created equal? Exploring the differences that enable evening dosing. Postgraduate medicine (2024)
Jennifer Hong, Gregory W Mattingly, Julie A Carbray, Takesha V Cooper, Robert L Findling, Martin Gignac, Paul E Glaser, Frank A Lopez, Vladamir Maletic, Roger S McIntyre, Adelaide S Robb, Manpreet Kaur Singh, Mark Stein, Stephen M Stahl
Expert Consensus Statement for Telepsychiatry and Attention Deficit Hyperactivity Disorder. CNS spectrums (2024)
Gregory W Mattingly, Julie A Carbray, Perry Roy, Frank A López
Are all ADHD medications created equal? Exploring the differences that enable evening dosing. Postgraduate medicine 136 (5) (2024)
Andrew J Cutler, Gregory W Mattingly, Vladimir Maletic
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational psychiatry 13 (1) (2023)
Andrew J Cutler, Gregory W Mattingly, Vladimir Maletic
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational psychiatry 13 (1) (2023)
Andrew J Cutler, Gregory W Mattingly, Vladimir Maletic
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational psychiatry 13 (1) (2023)
Gregory W Mattingly, Oscar Necking, Simon Nitschky Schmidt, Elin Reines, Hongye Ren
Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies. Current medical research and opinion (2023)
Andrew J Cutler, Gregory W Mattingly, Vladimir Maletic
Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder. Translational psychiatry 13 (1) (2023)
M Janelle Cambron-Mellott, Jaromir Mikl, Joana E Matos, Jennifer G Erensen, Kathleen Beusterien, Marc J Cataldo, Bernadette Hallissey, Gregory W Mattingly
Adult Patient Preferences for Long-Acting ADHD Treatments: A Discrete Choice Experiment. Patient preference and adherence 15 (2021)
Gin S Malhi, Pritha Das, Erica Bell, Gregory W Mattingly, Zola Mannie
Modelling resilience in adolescence and adversity: a novel framework to inform research and practice. Translational psychiatry 9 (1) (2019)